ClinicalTrials.Veeva

Find clinical trials for Diabetes in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Ulcer

Diabetes trials near Boston, MA, USA:

Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients (SUNRISE)

The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...

Active, not recruiting
Diabetes Mellitus, Type 1
Other: TOL-3021 Placebo
Biological: TOL-3021

Phase 2

Tolerion

Boston, Massachusetts, United States and 22 other locations

inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...

Not yet enrolling
Diabetic Nephropathies
Diabetes Mellitus Type 1
Drug: Sotagliflozin
Drug: Placebo

Phase 3

Alessandro Doria

Boston, Massachusetts, United States and 18 other locations

A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ technology in adults with type 2 diabetes using b...

Enrolling
Type 2 Diabetes Treated With Insulin
Device: t:slim X2 insulin pump with Control-IQ technology 1.5 and Dexcom G6 CGM
Device: Standard Therapy plus continuous glucose monitoring (CGM)
Tandem Diabetes Care
Tandem Diabetes Care

Boston, Massachusetts, United States and 20 other locations

The IMPACT study is a study to test a new experimental drug, IMCY-0098, for the treatment of type 1 diabetes (T1D).In most people with type ...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Placebo
Drug: IMCY-0098 1350 μg

Phase 2

Imcyse

Boston, Massachusetts, United States and 28 other locations

While data from the National Health and Nutrition Examination Survey (NHANES) estimate that 36.9% of patients with diabetes have CKD, only a...

Enrolling
Type2Diabetes
Chronic Kidney Diseases
Other: Alert-based computerized decision support
Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Enrolling
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Boston, Massachusetts, United States and 24 other locations

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Active, not recruiting
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT)

Phase 3

Prokidney

Providence, Rhode Island, United States and 45 other locations

of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...

Enrolling
Diabetes Mellitus, Type 2
Hypercortisolism
Drug: Mifepristone 300 MG [Korlym]
Drug: Placebo for mifepristone

Phase 4

Corcept Therapeutics
Corcept Therapeutics

Boston, Massachusetts, United States and 35 other locations

Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled with insulin therapy. The purpose of ...

Enrolling
Type 2 Diabetes
Device: Duodenal Mucosal Resurfacing (Sham)
Device: Duodenal Mucosal Resurfacing (DMR)
Fractyl Health

Boston, Massachusetts, United States and 62 other locations

This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...

Active, not recruiting
Type 2 Diabetes
Drug: Tirzepatide
Drug: Antihyperglycemic medication

Phase 4

Lilly
Lilly

Fall River, Massachusetts, United States and 88 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems